All News
Remission in PsA
❗️According to DAS28-CRP
*22% never achieve a state of remission
*< than half achieved at least stage of SR
❗️According to DAPSA28
*73% never achieve a state of remission
Are we that bad? Or do we need different measures? Or both?
@RheumNow
OP0262 #EULAR2022 https://t.co/6aeNW17VWg
Aurelie Najm AurelieRheumo ( View Tweet)
📈 Machine learning driven phenotyping in PsA
4 clusters of pts treated w/ Guselkumab identified 📊
1 cluster w/ higher BL disease burden associated w/ worst response
As fancy as it gets, not sure how to implement these in practice 🧐
@RheumNow #EULAR2022 OP0259 https://t.co/75X4ZqeEQJ
Aurelie Najm AurelieRheumo ( View Tweet)
@RichardPAConway @CatherineL_Hill @rheum_cat @RheumNow @KDAO2011 @uptoTate @AurelieRheumo Hello. @RheumNow reports @eular_org #EULAR2022 and teaches many. I learn as a tweeter. Way to go for all people tweeter this meeting. https://t.co/W3DuoVdfby
Janet Pope Janetbirdope ( View Tweet)
When Tweeps meet IRL #EULAR2022 #queensjubilee2022 @YelizPrior @DrMiniDey @chriswincup https://t.co/cnTFw2jjVd
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Sanchez-Bilboa at al. IV vs SC tocilizumab in 471 GCA patients. Equal efficacy. The authors report more adverse events with IV but actually this was purely due to longer follow up and per patient years it was the same. @RheumNow #EULAR2022 POS0272 https://t.co/2h7iIkMxjW
Richard Conway RichardPAConway ( View Tweet)
Just try and get into the great Tivoli Gardens after a day at #EULAR2022 https://t.co/qsGln5nH6S
Dr. John Cush RheumNow ( View Tweet)
Yusof et al @Yuz6Yusof COVID-19 in RTX treated patients. Significant efficacy of vaccination in both overall and severe COVID rates. Vaccination decreased risk HR 0.13 (0.03-0.51). Number comorbidities and low IgG increase risk @RheumNow #EULAR2022 OP0250 https://t.co/yD1tvs1UYt https://t.co/23XTtPb8fD
Links:
Richard Conway RichardPAConway ( View Tweet)
Pharmacodynamic effect of sequential #belimumab and #rituximab therapy in patients with systemic #lupus: BLISS-BELIEVE study
#EULAR2022
>CR https://t.co/AgBBuqYatW
ARD & RMD Open ARD_BMJ ( View Tweet)
#EULAR2022 virtual from my Copenhagen apartment this morning - you can’t watch three concurrent streams in person! @RheumNow https://t.co/Z74EOPn7kW
David Liew drdavidliew ( View Tweet)
WIN-Lupus. RCT of stopping treatment in SLE. All on HCQ. Randomised to stop Aza/MMF after being stable on for 2-3 years. Relapse proliferative nephritis in 25% vs 10%. Severe SLE flare 32% vs 13%. @RheumNow #EULAR2022 OP0280 https://t.co/IAcCoKw1YI
Links:
Richard Conway RichardPAConway ( View Tweet)
It was a pleasure to eat with editors of @RheumJnl at the first evening of #EULAR2022 @LatikaGupta_ @drdj @docrota @SteZhao @ElenaNikiUK
Best Rheumatology journal 🥳🥳 https://t.co/oTDWRUh0Fb
Emre Bilgin, MD dr_emrebilgin ( View Tweet)
So maybe, when it comes to delivering healthcare and telemedicine, we need to think about quality and efficiency? #EULAR2022 @RheumNow https://t.co/JMbQ1ZUB0o
David Liew drdavidliew ( View Tweet)
and, Robert Landewe argues, telemedicine is merely exchanging parcels of information.
Life visits deliver the chance for empathy #EULAR2022 @RheumNow https://t.co/2CKTJHfF7A
David Liew drdavidliew ( View Tweet)
Quality patient communication is actually critical to outcome #EULAR2022 @RheumNow https://t.co/37Z7hwrWmX
David Liew drdavidliew ( View Tweet)
What's the argument against that?
Fundamentally, empathy. The patient experience isn't just a product of miracle drugs - over time it's a multitude of factors that are what leads to happy patients
#EULAR2022 @RheumNow https://t.co/8GwhdT8cit
David Liew drdavidliew ( View Tweet)
and if we don't act, we leave it to the wild, wild west of the private market:
- designed for profit (not necessarily bad)
- but often at the cost of robust dedication to patient outcomes (always bad)
#EULAR2022 @RheumNow https://t.co/zfJWTZ3I1G
David Liew drdavidliew ( View Tweet)
In fact, in some select situations we can get by very well without seeing our patient at all?
#EULAR2022 @RheumNow https://t.co/4qcaj2KR9B
David Liew drdavidliew ( View Tweet)
So maybe telemedicine can bring us the efficiency that we badly need. In rheumatology, we're drowning in demand - is telemedicine part of the solution?
#EULAR2022 @RheumNow https://t.co/kHBIYRIvBA
David Liew drdavidliew ( View Tweet)
✨ Inflammatory #Myositis✨
👉 Excellent summary of Autoantibodies, Immune alterations and Distinct Phenotypes by Dr. Lisa Rider
#EULAR2022 https://t.co/KLzmLUGk9Z
Ashima Makol MD AshimaMakol ( View Tweet)
Watch: New 2022 EULAR RA Treatment Guidelines
https://t.co/mF4cKJLtbr
#EULAR2022 https://t.co/oI8p6gL0Tf
Links:
Dr. John Cush RheumNow ( View Tweet)